Nipocalimab for Myasthenia Gravis Treatment

By Rene Pretorius

April 30, 2025

Summary ​Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has
Enhancing Pediatric Pain Management in Portuguese Emergency Departments: Prog...
AI Pediatric Sarcoma Diagnosis: Improving Speed and Accuracy in Cancer Classi...
Urgent Need for Pediatric Heart Devices
AI Patient Education: Evaluating ChatGPT and Gemini for Pediatric Condition M...
Advancing Pediatric Leukemia Trial: Precision Medicine and Transformative Res...
Environmental Exposures and Pediatric Thyroid Cancer Risk: Key Findings from ...
Challenges in Accelerating Innovative Paediatric Medicine
Global Initiative Launches Access to Essential Childhood Cancer Medicines
Global Childhood Cancer Access
Boosting HPV Vaccine Uptake Among Young People Post-Pandemic
Advancing Newborn Screening for Sickle Cell Disease in Africa
Boosting Biopharma SMEs in Europe